1 |
N-2-methoxybenzyl
(7 times)
|
Toxicology (2 times)
|
NPS (3 times) 5-HT2A (1 time) hCES (1 time)
|
2014 Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
|
2 |
N-benzylmethoxy
(2 times)
|
Medicine (1 time)
|
DPIC (1 time)
|
2017 NBOMe hallucinogenic drug exposures reported to the Danish Poison Information Centre.
|
3 |
2,5-dimethoxy-N-benzylphenethylamines
(1 time)
|
Chemistry Techniques, Analytical (1 time)
|
2C-X (1 time) 5-HT2A (1 time) C. elegans (1 time)
|
2018 In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
|
4 |
25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine
(1 time)
|
Substance-Related Disorders (1 time)
|
BDNF (1 time) CPP (1 time) HAL (1 time)
|
2019 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
|
5 |
N-(2-methoxy) benzyl-phenethylamine
(1 time)
|
Environmental Health (1 time)
|
CTA (1 time)
|
2019 Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe.
|
6 |
N-methoxybenzyl derivatives of methoxyphenylethylamine
(1 time)
|
Toxicology (1 time)
|
HPLC-MS-MS (1 time) SWGTOX (1 time)
|
2014 High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
|
7 |
N-methoxybenzyl-methoxyphenylethylamine
(1 time)
|
Toxicology (1 time)
|
TM (1 time)
|
2015 Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
|
8 |
neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine
(1 time)
|
Neurology (1 time)
|
BMC (1 time) DOI (1 time) s.c (1 time)
|
2018 Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
|
9 |
number of N-2-methoxybenzyl-phenethylamine
(1 time)
|
Substance-Related Disorders (1 time)
|
BDNF (1 time) CPP (1 time) HAL (1 time)
|
2019 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
|